Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US9079884B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9079884-B2 |
| Application number | US-201314076955-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 11, 2013 |
| Priority date | Jun 30, 2008 |
| Publication date | Jul 14, 2015 |
| Grant date | Jul 14, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to processes for the preparation of substituted pyrimidine derivatives, useful as intermediates in the synthesis of histamine H 4 receptor modulators, and to intermediates in H4 modulator synthesis.
Opening claim text (preview).
We claim: 1. A compound of formula (XII) wherein PG 3 is a nitrogen protecting group selected from the group consisting of: —C(O)O—C(CH 3 ) 3 , —C(O)—CH 3 and —C(O)O—CH 2 CH 3 ; L 1 is CN; R c is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl, —CF 3 , cyclopropyl, and cyclobutyl; R 8 is selected from the group consisting of hydrogen and C 1-4 alkyl; Z is selected from the group consisting of N and CH; n is 1 or 2; R 9 , R 10 and R 11 are each independently selected from the group consisting of hydrogen and C 1-4 alkyl; or a pharmaceutically acceptable salts thereof. 2. A compound as in claim 1 , wherein the compound of formula (XII) is a compound of formula (XII-S) or a pharmaceutically acceptable salt thereof. 3. A compound as in claim 2 , wherein PG 3 is selected from the group consisting of —C(O)OCH 2 CH 3 and —C(O)OC(CH 3 ) 3 .
Drugs for immunological or allergic disorders · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
containing at least two amino groups bound to the carbon skeleton · CPC title
with hydrocarbon radicals, substituted by nitrogen atoms · CPC title
of an unsaturated carbon skeleton containing at least one six-membered aromatic ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.